<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04519008</url>
  </required_header>
  <id_info>
    <org_study_id>51/20</org_study_id>
    <nct_id>NCT04519008</nct_id>
  </id_info>
  <brief_title>Effectiveness and Security Testing of a Mobile App</brief_title>
  <official_title>Effectiveness and Security Testing of a Mobile App (BÂ·RIGHT) for Adolescents With Attention-Deficit/Hyperactivity Disorder and Emotion Dysregulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Consorci Sanitari del Maresme</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Consorci Sanitari del Maresme</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the effectiveness and security of a mobile App (beta version) for self-managing&#xD;
      emotion dysregulation in a pragmatic randomized controlled trial with 80 adolescents with&#xD;
      attention-deficit/hyperactivity disorder comparing 40 patients with treatment as usual (TAU)&#xD;
      with 40 patients with TAU plus the mobile App&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2021</start_date>
  <completion_date type="Anticipated">September 15, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Emotion dysregulation severity</measure>
    <time_frame>9 months</time_frame>
    <description>Severity of emotional dysregulation as measured by a single score from the The DERS (Difficulties in Emotion Regulation Scale) (range: 0-88; the higher the score, the more severe the emotion dysregulation severity).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Smartphone addiction</measure>
    <time_frame>9.months</time_frame>
    <description>Severity of smartphone addiction as measured by the Spanish version of the The Smartphone Addiction Scale (SAS) (range: 10-60; the higher the score, the more severe the smartphone addiction severity).</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Attention Deficit Disorder With Hyperactivity</condition>
  <arm_group>
    <arm_group_label>Treatment as usual plus mobile app</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Those who will receive naturalistic treatment in outpatient setting and also the mobile app</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment as usual</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Those who will receive naturalistic treatment in outpatient setting but not the mobile app</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Mobile app</intervention_name>
    <description>Medical device for improving emotion dysregulation</description>
    <arm_group_label>Treatment as usual plus mobile app</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Treatment as usual</intervention_name>
    <description>Bimonthly individual psychotherapy and psychostimulant medications</description>
    <arm_group_label>Treatment as usual</arm_group_label>
    <arm_group_label>Treatment as usual plus mobile app</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition) of&#xD;
             attention-deficit/hyperactivity disorder&#xD;
&#xD;
          -  High emotion dysregulation severity&#xD;
&#xD;
          -  Aged 14 to 17 years&#xD;
&#xD;
          -  Outpatient setting (Consorci Sanitari del Maresme&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Comorbidity with mental retardation&#xD;
&#xD;
          -  Comorbidity with psychotic disorder&#xD;
&#xD;
          -  Comorbidity with autism spectrum disorder&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>August 16, 2020</study_first_submitted>
  <study_first_submitted_qc>August 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 19, 2020</study_first_posted>
  <last_update_submitted>July 26, 2021</last_update_submitted>
  <last_update_submitted_qc>July 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperkinesis</mesh_term>
    <mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

